calcification

Original Contribution

Comparison of Heparin and Bivalirudin in Patients Undergoing Orbital Atherectomy

10/23/2017

Michael S. Lee , MD, DPM, FACFAS, FACC, FSCAI;

Orbital atherectomy modifies calcified plaque, thereby facilitating stent delivery and stent expansion. The ideal antithrombotic agent during orbital atherectomy is unknown. We compared the angiographic and clinical outcomes of heparin and...

Orbital atherectomy modifies...

10/23/2017

Journal of Invasive Cardiology

Original Contribution

Outcomes of Patients With a History of Coronary Artery Bypass Grafting Who Underwent Orbital Atherectomy for Severe Coronary Artery Calcification

09/30/2017

;

Evan Shlofmitz , DO;

Michael S. Lee , MD, DPM, FACFAS, FACC, FSCAI;

Richard A. Shlofmitz , MD;

We assess the angiographic and clinical outcomes of patients with a history of CABG surgery who underwent orbital atherectomy for the treatment of severely calcified coronary lesions. Despite a higher-risk baseline profile, patients with a...

We assess the angiographic and...

09/30/2017

Journal of Invasive Cardiology

Original Contribution

"Single-Operator" Technique for Advancing the Orbital Atherectomy Device

02/28/2017

Michael S. Lee , MD, DPM, FACFAS, FACC, FSCAI;

Richard A. Shlofmitz , MD;

;

We assessed the feasibility and safety of the “single-operator” technique in which the operator autonomously advanced the orbital atherectomy device while maintaining wire position.

We assessed the feasibility and...

02/28/2017

Journal of Invasive Cardiology

Original Contribution

Incidence of Bradycardia and Outcomes of Patients Who Underwent Orbital Atherectomy Without a Temporary Pacemaker

01/31/2017

Richard A. Shlofmitz , MD;

;

Michael S. Lee , MD, DPM, FACFAS, FACC, FSCAI;

We analyzed the incidence of bradycardia and the safety of patients with severely calcified coronary lesions who underwent orbital atherectomy without the insertion of a temporary pacemaker.

We analyzed the incidence of...

01/31/2017

Journal of Invasive Cardiology

Original Contribution

First Clinical Experience With Targeted REnal Nerve Demodulation (TREND-1) Using a Neurotropic Agent for the Treatment of Sympathetic Hypertension

01/15/2017

;

Horst Sievert , MD, FESC, FACC, FSCAI;

;

An evaluation of the feasibility and safety of a novel targeted neuromodulatory treatment for sympathetic hypertension involving a one-time local injection of neurotropic agents near renal nerves.

An evaluation of the feasibility...

01/15/2017

Journal of Invasive Cardiology

Original Contribution

Impact of Impaired Renal Function in Patients With Severely Calcified Coronary Lesions Treated With Orbital Atherectomy

01/15/2017

Richard A. Shlofmitz , MD;

Evan Shlofmitz , DO;

Michael S. Lee , MD, DPM, FACFAS, FACC, FSCAI;

;

We evaluated the clinical outcomes of patients with chronic kidney disease who underwent orbital atherectomy for severe coronary artery calcification prior to stent implantation.

We evaluated the clinical...

01/15/2017

Journal of Invasive Cardiology

Original Contribution

Gender-Based Differences in Outcomes After Orbital Atherectomy for the Treatment of De Novo Severely Calcified Coronary Lesions

10/28/2016

;

Richard A. Shlofmitz , MD;

Evan Shlofmitz , DO;

Sanjum S. Sethi , MD, MPH;

Michael S. Lee , MD, DPM, FACFAS, FACC, FSCAI;

This study evaluated the relationship between gender and angiographic and clinical outcomes in patients with severely calcified lesions who underwent orbital atherectomy.

This study evaluated the...

10/28/2016

Journal of Invasive Cardiology

Commentary

Orbital Atherectomy in Women 2.0 – Another Brick in the Wall

10/28/2016

Mladen I. Vidovich , MD;

Konstantinos V. Voudris , MD;

The authors discuss this month's article by Lee et al, which focuses on device-specific outcomes and reports similar angiographic and clinical outcomes between females and males undergoing orbital atherectomy for plaque modification.

The authors discuss this month's...

10/28/2016

Journal of Invasive Cardiology

Original Contribution

Alternative Rota-Flush Solution for Patients With Severe Coronary Artery Calcification who Undergo Rotational Atherectomy

06/15/2016

Moo-Hyun Kim , MD, PhD;

Michael S. Lee , MD, DPM, FACFAS, FACC, FSCAI;

Seung-Woon Rha , MD, PhD;

We assessed the feasibility and safety of a rota-flush solution with 10,000 U of unfractionated heparin in 1 L of normal saline in rotational atherectomy patients as an alternative to the routinely used solution, which includes the RotaGlide...

We assessed the feasibility and...

06/15/2016

Journal of Invasive Cardiology

Original Contribution

Outcomes After Orbital Atherectomy of Severely Calcified Left Main Lesions: Analysis of the ORBIT II Study

03/15/2016

;

Michael S. Lee , MD, DPM, FACFAS, FACC, FSCAI;

Brad J. Martinsen , PhD;

Richard A. Shlofmitz , MD;

Matthew J. Frigault , MD;

Evan Shlofmitz , DO;

This study evaluated the safety and efficacy of coronary orbital atherectomy to prepare severely calcified protected LM artery lesions for stent placement.

This study evaluated the safety...

03/15/2016

Journal of Invasive Cardiology